Bluejay Current Ratio from 2010 to 2024

BJDX Stock  USD 0.53  0.01  1.92%   
Bluejay Diagnostics Current Ratio yearly trend continues to be fairly stable with very little volatility. Current Ratio will likely drop to 1.59 in 2024. Current Ratio is a liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities. View All Fundamentals
 
Current Ratio  
First Reported
2010-12-31
Previous Quarter
1.66863538
Current Value
1.59
Quarterly Volatility
8.25324379
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bluejay Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bluejay main balance sheet or income statement drivers, such as Net Interest Income of 173.1 K, Depreciation And Amortization of 820 K or Selling General Administrative of 2.7 M, as well as many exotic indicators such as Price To Sales Ratio of 24.62, Dividend Yield of 0.0 or PTB Ratio of 0.49. Bluejay financial statements analysis is a perfect complement when working with Bluejay Diagnostics Valuation or Volatility modules.
  
This module can also supplement various Bluejay Diagnostics Technical models . Check out the analysis of Bluejay Diagnostics Correlation against competitors.
For more information on how to buy Bluejay Stock please use our How to Invest in Bluejay Diagnostics guide.

Latest Bluejay Diagnostics' Current Ratio Growth Pattern

Below is the plot of the Current Ratio of Bluejay Diagnostics over the last few years. It is a liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities. Bluejay Diagnostics' Current Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bluejay Diagnostics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 17.41 X10 Years Trend
Slightly volatile
   Current Ratio   
       Timeline  

Bluejay Current Ratio Regression Statistics

Arithmetic Mean3.24
Geometric Mean0.96
Coefficient Of Variation254.45
Mean Deviation4.42
Median0.52
Standard Deviation8.25
Sample Variance68.12
Range31.9049
R-Value0.34
Mean Square Error64.90
R-Squared0.12
Significance0.22
Slope0.63
Total Sum of Squares953.62

Bluejay Current Ratio History

2024 1.59
2023 1.67
2022 7.19
2021 32.43
2020 0.57

About Bluejay Diagnostics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Bluejay Diagnostics income statement, its balance sheet, and the statement of cash flows. Bluejay Diagnostics investors use historical funamental indicators, such as Bluejay Diagnostics's Current Ratio, to determine how well the company is positioned to perform in the future. Although Bluejay Diagnostics investors may use each financial statement separately, they are all related. The changes in Bluejay Diagnostics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bluejay Diagnostics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Bluejay Diagnostics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Bluejay Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Ratio 1.67  1.59 
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bluejay Diagnostics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bluejay Diagnostics' short interest history, or implied volatility extrapolated from Bluejay Diagnostics options trading.

Pair Trading with Bluejay Diagnostics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bluejay Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bluejay Diagnostics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bluejay Stock

  0.83CVS CVS Health CorpPairCorr
  0.75MDT Medtronic PLC Financial Report 23rd of May 2024 PairCorr
  0.64IART Integra LifeSciencesPairCorr

Moving against Bluejay Stock

  0.83GKOS Glaukos CorpPairCorr
  0.83INSP Inspire Medical SystemsPairCorr
  0.75KIDS Orthopediatrics CorpPairCorr
  0.75SWAV Shockwave Medical Financial Report 13th of May 2024 PairCorr
  0.54SNDA Sonida Senior LivingPairCorr
The ability to find closely correlated positions to Bluejay Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bluejay Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bluejay Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bluejay Diagnostics to buy it.
The correlation of Bluejay Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bluejay Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bluejay Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bluejay Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bluejay Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bluejay Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bluejay Diagnostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bluejay Diagnostics Stock:
Check out the analysis of Bluejay Diagnostics Correlation against competitors.
For more information on how to buy Bluejay Stock please use our How to Invest in Bluejay Diagnostics guide.
Note that the Bluejay Diagnostics information on this page should be used as a complementary analysis to other Bluejay Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Bluejay Stock analysis

When running Bluejay Diagnostics' price analysis, check to measure Bluejay Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluejay Diagnostics is operating at the current time. Most of Bluejay Diagnostics' value examination focuses on studying past and present price action to predict the probability of Bluejay Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluejay Diagnostics' price. Additionally, you may evaluate how the addition of Bluejay Diagnostics to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Is Bluejay Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluejay Diagnostics. If investors know Bluejay will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluejay Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(9.08)
Return On Assets
(0.70)
Return On Equity
(1.38)
The market value of Bluejay Diagnostics is measured differently than its book value, which is the value of Bluejay that is recorded on the company's balance sheet. Investors also form their own opinion of Bluejay Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Bluejay Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluejay Diagnostics' market value can be influenced by many factors that don't directly affect Bluejay Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bluejay Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bluejay Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluejay Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.